newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®

Nationally Syndicated Radio Programming Will Educate and Support SCD Patients TORRANCE, Calif., Sept. 28, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle c